Science Explorer Back to mapMap
Discussion
Researcher · Istituto Oncologico Veneto · Italy

Fabio Girardi

Fabio Girardi publishes mostly in Oncology, Cancer Research and Genetics, on topics such as Breast Cancer Treatment Studies, Glioma Diagnosis and Treatment and Childhood Cancer Survivors' Quality of Life.

ORCID 0000-0001-7094-7986 OpenAlex
World rank
#454,429
of 7,710,434 ranked researchers
Rank in Italy
#12,504
of 242,206
Works
137
Citations
1.9k
Citations per work
13.6
h-index
19
i10-index 24Top 25% in Oncology
Fabio Girardi

What does Fabio Girardi research?

Fabio Girardi's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 75 works · 54.7% of their workMedicine: 75 works · 54.7% of their workOncology: 33 works · 24.1% of their workGenetics: 14 works · 10.1% of their workPulmonary and Respiratory Medicine: 13 works · 9.5% of their workEpidemiology: 8 works · 5.5% of their workPediatrics, Perinatology and Child Health: 8 works · 5.5% of their workEverything else: 48 works · 34.7% of their workLife Sciences: 15 works · 10.6% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 10.6% of their workCancer Research: 15 works · 10.6% of their workTHEIR WORKFabio Girardi137works
Life Sciences11%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7554.7%
  2. Everything else4834.7%
    1. Biochemistry, Genetics and Molecular Biology1510.6%
  1. 1Oncology24% of their works
  2. 2Cancer Research11% of their works
  3. 3Genetics10% of their works
  4. 4Pulmonary and Respiratory Medicine10% of their works
  5. 5Epidemiology6% of their works
  6. 6Pediatrics, Perinatology and Child Health6% of their works

Research topics

Which keywords describe Fabio Girardi's research?

The keywords of their largest research topics: Radiotherapy, Immunotherapy, Survival Analysis, Breast Tumours, Gene Expression, Glioblastoma, Temozolomide and Breast Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Radiotherapy382 topics
  2. Immunotherapy323 topics
  3. Survival Analysis272 topics
  4. Breast Tumours201 topic
  5. Gene Expression201 topic
  6. Glioblastoma181 topic
  7. Temozolomide181 topic
  8. Breast Cancer152 topics
  9. Genetic Alterations142 topics
  10. Childhood Cancer Survivor Study91 topic
  11. Pediatric Quality of Life Inventory91 topic
  12. CDK4/6 Inhibitors81 topic
  13. Palbociclib81 topic
  14. Acute Lymphoblastic Leukemia71 topic
  15. Brain Metastases71 topic
  16. Childhood Cancer71 topic
  17. Dermoscopy71 topic
  18. HER271 topic
  19. Melanoma71 topic
  20. Radiosurgery71 topic
  21. Trastuzumab71 topic

Where does Fabio Girardi work?

Fabio Girardi's main affiliation in the publication record is Istituto Oncologico Veneto, Italy.

How many publications and citations does Fabio Girardi have?

OpenAlex counts 137 works and 1,868 citations for Fabio Girardi, an h-index of 19, ranking #454,429 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Fabio Girardi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.